https://www.selleckchem.com/pr....oducts/nazartinib-eg
ratio of AD and we speculate that this effect is mediated via a beneficial impact of AMY1A copy number on episodic memory performance. Our study suggests that the degree of α-amylase activity in the brain is affected by AMY1A copy number and gender, in addition to AD pathology. The study further suggests that very high AMY1A copy number is associated with a decreased hazard ratio of AD and we speculate that this effect is mediated via a beneficial impact of AMY1A copy number on episodic memory performance. The objectiv